Therapeutics: Interferon α/β receptor 1 (IFNAR1); tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)

Infectious disease

INDICATION: Acute lung injury; respiratory distress syndrome (RDS)

Cell culture and mouse studies suggest that combining inhibitors of IFNAR1

Read the full 192 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE